Michael Bohm
Overview
Explore the profile of Michael Bohm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1151
Citations
49753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallone G, Savoca F, Miccoli D, Bohm M, De Ferrari G, Gottlieb S, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088236
Background: Patients with heart failure with reduced ejection fraction (HFrEF) have a heightened stroke risk. However, stroke as an endpoint in heart failure trials remains under-reported. Objectives: The authors sought...
2.
Charpentier C, Berzow D, Le Hingrat Q, Kaiser R, Gomes P, Miranda A, et al.
Clin Infect Dis
. 2025 Mar;
PMID: 40071658
Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic...
3.
Senni M, Paruchuru P, Shi V, Bohm M
Eur J Heart Fail
. 2025 Mar;
PMID: 40058967
No abstract available.
4.
Bohm M, Butler J, Coats A, Lauder L, Mahfoud F, Filippatos G, et al.
Eur Heart J
. 2025 Mar;
PMID: 40037646
Background And Aims: Hypertension has a high prevalence in heart failure with preserved ejection fraction (HFpEF), which can be controlled, uncontrolled, or even resistant. The effects of empagliflozin on systolic...
5.
Skouri H, Girerd N, Monzo L, Petrie M, Bohm M, Adamo M, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 40012353
Despite major advancements in heart failure (HF) management and guideline recommendations over the past two decades, real-world evidence highlights suboptimal implementation of guideline-directed medical therapy (GDMT) for HF with reduced...
6.
Emrich I, Obeid R, Geisel J, Fliser D, Bohm M, Heine G, et al.
Nutrients
. 2025 Feb;
17(4).
PMID: 40004955
Patients suffering from chronic kidney disease (CKD) have a high risk of premature cardiovascular morbidity and mortality. It has been suggested that elevated homocysteine (Hcy) or disturbances in the transmethylation...
7.
Mahfoud F, Townsend R, Kandzari D, Mancia G, Whitbourn R, Lauder L, et al.
JACC Adv
. 2025 Feb;
4(3):101606.
PMID: 39985884
Background: Renal denervation (RDN) lowers blood pressure (BP) in patients with uncontrolled hypertension. Current guidelines recommend RDN for patients with uncontrolled BP despite the use of antihypertensive (AH) medications. Durability...
8.
Braumann S, Macherey-Meyer S, Polzin A, Costard-Jackle A, Morbach C, Haring B, et al.
Circulation
. 2025 Feb;
PMID: 39937049
No abstract available.
9.
Bavendiek U, Berliner D, Thomas N, Liu X, Schwab J, Rieth A, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39838553
No abstract available.
10.
Gonzalez-Juanatey J, Otero-Garcia O, Bohm M
Eur J Heart Fail
. 2025 Jan;
PMID: 39834291
No abstract available.